Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYCBP2 - Effect of protease-resistant (PML-RAR)α on U937 cell line
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYCBP2 - Small-molecule DOT1L inhibitor EPZ004777 effect on mixed lineage leukemia cells: time course
MYCBP2 - Model of cerebral aging and Alzheimer's disease: temporal cortex
MYCBP2 - Recombinant Interferon α effect on natural killer cells in vitro
MYCBP2 - Postmortem temporal cortex from Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort: astrocytes
MYCBP2 - Alzheimer's disease: neurofibrillary tangles
MYCBP2 - Cerebellar cortex in schizophrenia
MYCBP2 - Schizophrenia: endothelial and neuronal cells from postmortem dorsolateral prefrontal cortex tissue
MYCBP2 - Multiple sclerosis: peripheral blood mononuclear cells
MYCBP2 - Systemic lupus erythematosus CD3+ T cells
MYCBP2 - HIV encephalitis: brain frontal cortex
MYCBP2 - Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
MYCBP2 - Fetal and adult reticulocytes
MYCBP2 - Saliva of pre-treatment pancreatic cancer patients
MYCBP2 - Acute myeloid leukemia cell lines with high Ecotropic Viral Integration site 1 expression
MYCBP2 - Multiple dorsal thalamic nuclei
MYCBP2 - Multiple sclerosis: brain lesions
MYCBP2 - Vulvar intraepithelial neoplasia
MYCBP2 - Schizophrenia: postmortem anterior prefrontal cortex
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on